BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Janssen Therapeutics 

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for LGBT Students 7/17/2013 8:02:08 AM    More...
Janssen Therapeutics Release: Survey of Participants from Landmark GRACE Trial Provides Patients' Perspectives From an HIV Clinical Study 5/31/2013 9:18:33 AM    More...
Janssen Therapeutics LINCC™ Program Continues Its Commitment to Underserved Populations With Charitable Contributions to 16 HIV/AIDS Organizations Across the U.S. 4/24/2013 10:20:28 AM    More...
Janssen Therapeutics Release: FDA Approves Prescribing Information Update for EDURANT® (Rilpivirine) to Include 96-Week Data in HIV-1-Infected Treatment-Naive Adult Patients 12/11/2012 9:09:14 AM    More...
Janssen Therapeutics's Prezista 800 Mg Tablet Receives FDA Approval 11/12/2012 7:07:49 AM    More...
Janssen Therapeutics Release: Award-Winning Documentary, The Other City, Returns to Washington, D.C. for AIDS 2012 7/24/2012 11:07:01 AM    More...
Janssen Therapeutics Release: FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 5/29/2012 11:06:43 AM    More...
Janssen Therapeutics Release: Watching, Reading and Listening: A New Way to Interact with Patient Information 4/25/2012 9:12:21 AM    More...
Janssen Therapeutics Establishes Point Scholarship for LGBT Students 4/12/2012 2:43:45 PM    More...
FDA Approves Janssen Therapeutics INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients With HIV-1, Following Priority Review 3/27/2012 7:23:11 AM    More...
12